loadpatents
name:-0.052813053131104
name:-0.032423973083496
name:-0.011023998260498
Kole; Ryszard Patent Filings

Kole; Ryszard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kole; Ryszard.The latest application filed is for "compound and method for treating myotonic dystrophy".

Company Profile
11.30.47
  • Kole; Ryszard - Corvallis OR
  • Kole; Ryszard - Cambridge MA
  • Kole; Ryszard - Bellevue WA
  • Kole; Ryszard - Chapel Hill NC
  • Kole, Ryszard - Chaple Hill NC
  • Kole; Ryszard - Orange County NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compound and method for treating myotonic dystrophy
Grant 11,236,329 - Moulton , et al. February 1, 2
2022-02-01
Compound And Method For Treating Myotonic Dystrophy
App 20220002733 - Hanson; Gunnar J. ;   et al.
2022-01-06
Oligonucleotide analogues targeting human LMNA
Grant 11,071,749 - Kole , et al. July 27, 2
2021-07-27
Multiple Exon Skipping Compositions For Dmd
App 20210180060 - SAZANI; Peter ;   et al.
2021-06-17
Compound and method for treating myotonic dystrophy
Grant 10,927,378 - Kole , et al. February 23, 2
2021-02-23
Oligonucleotide Analogues Targeting Human Lmna
App 20210010001 - Erdos; Michael R. ;   et al.
2021-01-14
Oligonucleotide analogues targeting human LMNA
Grant 10,822,608 - Erdos , et al. November 3, 2
2020-11-03
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
App 20200283776 - Sazani; Peter L. ;   et al.
2020-09-10
Oligonucleotide Analogues Targeting Human Lmna
App 20200147119 - KOLE; Ryszard ;   et al.
2020-05-14
Multiple Exon Skipping Compositions For Dmd
App 20190284556 - Sazani; Peter ;   et al.
2019-09-19
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
Grant 10,398,721 - Kole , et al. Sep
2019-09-03
Compound And Method For Treating Myotonic Dystrophy
App 20190264210 - Kole; Ryszard ;   et al.
2019-08-29
Multiple Exon Skipping Compositions For Dmd
App 20190127738 - SAZANI; Peter ;   et al.
2019-05-02
Oligonucleotide Analogues Targeting Human Lmna
App 20190127735 - Erdos; Michael R. ;   et al.
2019-05-02
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
App 20190017052 - Sazani; Peter L. ;   et al.
2019-01-17
Compound and method for treating myotonic dystrophy
Grant 10,106,796 - Kole , et al. October 23, 2
2018-10-23
Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lmna
App 20180271893 - KOLE; RYSZARD ;   et al.
2018-09-27
Oligonucleotide analogues targeting human LMNA
Grant 10,076,536 - Kole , et al. September 18, 2
2018-09-18
Oligonucleotide Analogues Targeting Human Lmna
App 20180092938 - KOLE; Ryszard ;   et al.
2018-04-05
Multiple Exon Skipping Compositions For Dmd
App 20180066259 - SAZANI; Peter ;   et al.
2018-03-08
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
App 20180051290 - Sazani; Peter L. ;   et al.
2018-02-22
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
Grant 9,833,468 - Kole , et al. December 5, 2
2017-12-05
Multiple Exon Skipping Compositions For Dmd
App 20170292125 - SAZANI; Peter ;   et al.
2017-10-12
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
App 20170191067 - Sazani; Peter L. ;   et al.
2017-07-06
Oligonucleotide analogues targeting human LMNA
Grant 9,682,097 - Kole , et al. June 20, 2
2017-06-20
Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lmna
App 20170051278 - Kole; Ryszard ;   et al.
2017-02-23
Multiple exon skipping compositions for DMD
Grant 9,453,225 - Sazani , et al. September 27, 2
2016-09-27
Multiple exon skipping compositions for DMD
Grant 9,447,417 - Sazani , et al. September 20, 2
2016-09-20
Multiple exon skipping compositions for DMD
Grant 9,447,416 - Sazani , et al. September 20, 2
2016-09-20
Multiple exon skipping compositions for DMD
Grant 9,434,948 - Sazani , et al. September 6, 2
2016-09-06
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
Grant 9,326,992 - Kole , et al. May 3, 2
2016-05-03
Oligonucleotide Analogues Targeting Human Lmna
App 20160102307 - Kole; Ryszard ;   et al.
2016-04-14
Multiple exon skipping compositions for DMD
Grant 9,234,198 - Sazani , et al. January 12, 2
2016-01-12
Multiple Exon Skipping Compositions For Dmd
App 20160002637 - Sazani; Peter ;   et al.
2016-01-07
Multiple Exon Skipping Compositions For Dmd
App 20160002633 - Sazani; Peter ;   et al.
2016-01-07
Multiple Exon Skipping Compositions For Dmd
App 20160002634 - Sazani; Peter ;   et al.
2016-01-07
Multiple Exon Skipping Compositions For Dmd
App 20150376618 - Sazani; Peter ;   et al.
2015-12-31
Multiple Exon Skipping Compositions For Dmd
App 20150376617 - SAZANI; PETER ;   et al.
2015-12-31
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
App 20150252371 - Sazani; Peter L. ;   et al.
2015-09-10
Oligonucleotide analogues targeting human LMNA
Grant 9,066,967 - Kole , et al. June 30, 2
2015-06-30
Oligonucleotide Inhibitors Of Dna Methyltransferases And Their Use In Treating Diseases
App 20150167004 - Sledziewski; Andrew Z. ;   et al.
2015-06-18
Multiple Exon Skipping Compositions For Dmd
App 20150152415 - SAZANI; Peter ;   et al.
2015-06-04
Compound And Method For Treating Myotonic Dystrophy
App 20150141321 - Kole; Ryszard ;   et al.
2015-05-21
Compound And Method For Treating Myotonic Dystrophy
App 20150080311 - Moulton; Hong M. ;   et al.
2015-03-19
Multiple exon skipping compositions for DMD
Grant 8,871,918 - Sazani , et al. October 28, 2
2014-10-28
Multiple exon skipping compositions for DMD
Grant 8,865,883 - Sazani , et al. October 21, 2
2014-10-21
Compound and method for treating myotonic dystrophy
Grant 8,835,402 - Kole , et al. September 16, 2
2014-09-16
Compound and method for treating myotonic dystrophy
Grant 8,741,863 - Moulton , et al. June 3, 2
2014-06-03
Compound And Method For Treating Myotonic Dystrophy
App 20140107013 - Kole; Ryszard ;   et al.
2014-04-17
Multiple Exon Skipping Compositions For Dmd
App 20140094500 - SAZANI; Peter ;   et al.
2014-04-03
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
App 20140057968 - Sazani; Peter L. ;   et al.
2014-02-27
Oligonucleotide Analogues Targeting Human Lmna
App 20140024821 - Kole; Ryszard ;   et al.
2014-01-23
Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lmna
App 20140024698 - Kole; Ryszard ;   et al.
2014-01-23
Chimeric oligomeric compounds for modulation of splicing
Grant 8,501,703 - Bennett , et al. August 6, 2
2013-08-06
Multiple Exon Skipping Compositions For Dmd
App 20130190390 - SAZANI; Peter ;   et al.
2013-07-25
Soluble Thf Receptors And Their Use In Treatment Of Disease
App 20120142759 - Sazani; Peter L. ;   et al.
2012-06-07
Compound And Method For Treating Myotonic Dystrophy
App 20120058946 - Moulton; Hong M. ;   et al.
2012-03-08
Compound And Method For Treating Myotonic Dystrophy
App 20110269665 - Kole; Ryszard
2011-11-03
Splice Switching Oligomers For Tnf Superfamily Receptors And Their Use In Treatment Of Disease
App 20110237521 - Sazani; Peter L. ;   et al.
2011-09-29
Soluble HER2 and HER3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease
Grant 7,884,194 - Kole , et al. February 8, 2
2011-02-08
Soluble TNF receptors and their use in treatment of disease
Grant 7,785,834 - Sazani , et al. August 31, 2
2010-08-31
Multiple Exon Skipping Compositions For Dmd
App 20100130591 - Sazani; Peter ;   et al.
2010-05-27
Compound And Method For Treating Myotonic Dystrophy
App 20100016215 - Moulton; Hong M. ;   et al.
2010-01-21
Soluble HER2 and HER3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease
App 20090105139 - Kole; Ryszard ;   et al.
2009-04-23
Soluble TNF receptors and their use in treatment of disease
App 20070249538 - Sazani; Peter L. ;   et al.
2007-10-25
Splice switch oligomers for TNF superfamily receptors and their use in treatment of disease
App 20070105807 - Sazani; Peter L. ;   et al.
2007-05-10
Methods and compositions for modification of splicing of pre-mRNA
App 20040137472 - Kole, Ryszard
2004-07-15
Stable alteration on pre-mRNA splicing patterns by modified RNAs
App 20030114411 - Kole, Ryszard ;   et al.
2003-06-19
Stable Alteration Of Pre-mrna Splicing Patterns By Modified Rnas
App 20030036519 - KOLE, RYSZARD ;   et al.
2003-02-20
Antisense oligonucleotides which combat aberrant splicing and methods of using the same
Grant 5,976,879 - Kole , et al. November 2, 1
1999-11-02
Antisense oligonucleotides which combat aberrant splicing and methods of using the same
Grant 5,916,808 - Kole , et al. June 29, 1
1999-06-29
Antisense oligonucleotides which combat aberrant splicing and methods of using the same
Grant 5,665,593 - Kole , et al. September 9, 1
1997-09-09
Antisense oligonucleotides which combat aberrant splicing and methods of using the same
Grant 5,627,274 - Kole , et al. May 6, 1
1997-05-06
Company Registrations
NCAGE Code4AM09KOLE RYSZARD
CAGE Code4AM09KOLE, RYSZARD
SEC0001432278kole Ryszard

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed